Numinus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted TherapyPRNewsWire • 05/25/23
Numinus Wellness poised to outpace 'retrenching' psychedelic peers, Water Tower Research saysProactive Investors • 04/27/23
Numinus Wellness launches new clinic licensing platform to accelerate expansionProactive Investors • 04/11/23
Numinus Launches new Clinic Licensing Platform, the Numinus Network, to Accelerate ExpansionPRNewsWire • 04/11/23
Numinus Launches the Practitioner Certification Pathway - a Complete Psychedelic-Assisted Therapy Training ProgramPRNewsWire • 03/27/23
Numinus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023PRNewsWire • 03/22/23
Numinus Wellness chief clinical officer's contributions to mental health disorder studies featured in four peer-reviewed papersProactive Investors • 03/21/23
Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023PRNewsWire • 03/21/23
Numinus to Participate in a Water Tower Research Fireside Chat on Tuesday, February 28, 2023PRNewsWire • 02/24/23
Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of ShareholdersPRNewsWire • 02/15/23
Numinus Receives Clinical Trial Application Approval from Health Canada for Experiential Psychedelic-Assisted Therapy Training using Psilocybe Cubensis TeaPRNewsWire • 02/01/23
Psychedelics Company Numinus Wellness Consolidates Recent Surge Higher: What's Going On?Benzinga • 01/18/23
Numinus Wellness reports surge in 1Q revenue as Novamind acquisition beds inProactive Investors • 01/17/23